Xiaoying Yu1,2, Jordan R Westra1, Thomas P Giordano3,4, Abbey B Berenson2,5, Jacques G Baillargeon1, Yong-Fang Kuo1,2. 1. Office of Biostatistics, Department of Preventive Medicine and Population Health. 2. Center for Interdisciplinary Research in Women's Health, University of Texas Medical Branch, Galveston. 3. Department of Medicine, Baylor College of Medicine. 4. Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey VA Medical Center, Houston. 5. Department of Obstetrics & Gynecology, The University of Texas Medical Branch at Galveston, TX, USA.
Abstract
OBJECTIVE: People with HIV infection experience excessive mortality compared with their noninfected counterparts. It is unclear whether the impact of HIV infection on mortality varies by comorbidities or whether sex difference exists in this relationship. This study assessed the effect of newly diagnosed HIV infection on overall mortality among Medicare beneficiaries for both disabled and older adults (≥65 years old) based on their original entitlement. METHODS: We constructed a retrospective matched cohort using a 5% nationally representative sample of Medicare beneficiaries between 1996 and 2015. People with incident HIV diagnoses were individually matched to up to three controls based on demographics. Cox proportional hazards models adjusted for baseline demographics and comorbidities were used to assess the effect of HIV status on survival among four disabled groups by sex strata. Within each stratum, interactions between comorbidity variables and HIV status were examined. RESULTS: People with HIV, especially older women, had a higher prevalence of baseline comorbidities than controls. HIV--mortality association varied according to sex in older adults (P = 0.004). Comorbidity--HIV interactions were more pronounced in disabled groups (P < 0.0001). People with HIV with more chronic conditions had a less pronounced increase in the risk of death than those with fewer conditions, compared with uninfected controls. CONCLUSION: Medicare enrollees with newly diagnosed HIV had more prevalent baseline comorbidities and were at higher risk of death than people without HIV. HIV infection has a more pronounced effect among those with fewer comorbidities. Sex differences in HIV--mortality association exist among older Medicare enrollees.
OBJECTIVE: People with HIV infection experience excessive mortality compared with their noninfected counterparts. It is unclear whether the impact of HIV infection on mortality varies by comorbidities or whether sex difference exists in this relationship. This study assessed the effect of newly diagnosed HIV infection on overall mortality among Medicare beneficiaries for both disabled and older adults (≥65 years old) based on their original entitlement. METHODS: We constructed a retrospective matched cohort using a 5% nationally representative sample of Medicare beneficiaries between 1996 and 2015. People with incident HIV diagnoses were individually matched to up to three controls based on demographics. Cox proportional hazards models adjusted for baseline demographics and comorbidities were used to assess the effect of HIV status on survival among four disabled groups by sex strata. Within each stratum, interactions between comorbidity variables and HIV status were examined. RESULTS: People with HIV, especially older women, had a higher prevalence of baseline comorbidities than controls. HIV--mortality association varied according to sex in older adults (P = 0.004). Comorbidity--HIV interactions were more pronounced in disabled groups (P < 0.0001). People with HIV with more chronic conditions had a less pronounced increase in the risk of death than those with fewer conditions, compared with uninfected controls. CONCLUSION: Medicare enrollees with newly diagnosed HIV had more prevalent baseline comorbidities and were at higher risk of death than people without HIV. HIV infection has a more pronounced effect among those with fewer comorbidities. Sex differences in HIV--mortality association exist among older Medicare enrollees.
Authors: Beatriz Grinsztejn; Mina C Hosseinipour; Heather J Ribaudo; Susan Swindells; Joseph Eron; Ying Q Chen; Lei Wang; San-San Ou; Maija Anderson; Marybeth McCauley; Theresa Gamble; Nagalingeshwaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Jose H S Pilotto; Sheela V Godbole; Suwat Chariyalertsak; Marineide Gonçalves de Melo; Kenneth H Mayer; Susan H Eshleman; Estelle Piwowar-Manning; Joseph Makhema; Lisa A Mills; Ravindre Panchia; Ian Sanne; Joel Gallant; Irving Hoffman; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Diane Havlir; Myron S Cohen Journal: Lancet Infect Dis Date: 2014-03-04 Impact factor: 25.071
Authors: Amanda M Kong; Alexis Pozen; Kathryn Anastos; Elizabeth A Kelvin; Denis Nash Journal: AIDS Patient Care STDS Date: 2019-03 Impact factor: 5.078
Authors: Kate Buchacz; Rose K Baker; Anne C Moorman; James T Richardson; Kathleen C Wood; Scott D Holmberg; John T Brooks Journal: AIDS Date: 2008-07-11 Impact factor: 4.177
Authors: Oghenowede Eyawo; Conrado Franco-Villalobos; Mark W Hull; Adriana Nohpal; Hasina Samji; Paul Sereda; Viviane D Lima; Jeannie Shoveller; David Moore; Julio S G Montaner; Robert S Hogg Journal: BMC Infect Dis Date: 2017-02-27 Impact factor: 3.090
Authors: Adam Trickey; Margaret T May; Janne Vehreschild; Niels Obel; Michael John Gill; Heidi Crane; Christoph Boesecke; Hasina Samji; Sophie Grabar; Charles Cazanave; Matthias Cavassini; Leah Shepherd; Antonella d'Arminio Monforte; Colette Smit; Michael Saag; Fiona Lampe; Vicky Hernando; Marta Montero; Robert Zangerle; Amy C Justice; Timothy Sterling; Jose Miro; Suzanne Ingle; Jonathan A C Sterne Journal: PLoS One Date: 2016-08-15 Impact factor: 3.240
Authors: Gina Turrini; Stephanie S Chan; Pamela W Klein; Stacy M Cohen; Antigone Dempsey; Heather Hauck; Laura W Cheever; Andre R Chappel Journal: PLoS One Date: 2020-11-05 Impact factor: 3.240
Authors: Mohammed Siddiqui; T J Moore; Dustin M Long; Greer A Burkholder; Amanda Willig; Christina Wyatt; Sonya Heath; Paul Muntner; Edgar Turner Overton Journal: AIDS Res Hum Retroviruses Date: 2022-08-23 Impact factor: 1.723
Authors: Xiaoying Yu; Jacques Baillargeon; Abbey B Berenson; Jordan R Westra; Thomas P Giordano; Yong-Fang Kuo Journal: AIDS Date: 2022-05-25 Impact factor: 4.632
Authors: Boyoung Park; Yunsu Choi; Jung Ho Kim; Hye Seong; Youn Jeong Kim; Myungsun Lee; Jaehyun Seong; Shin-Woo Kim; Joon Young Song; Hee-Jung Choi; Dae Won Park; Hyo Youl Kim; Jun Yong Choi; Sang Il Kim; Bo-Youl Choi Journal: Int J Environ Res Public Health Date: 2022-09-18 Impact factor: 4.614